Your browser doesn't support javascript.
loading
Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol.
Lesueur, Paul; Lequesne, Justine; Grellard, Jean-Michel; Dugué, Audrey; Coquan, Elodie; Brachet, Pierre-Emmanuel; Geffrelot, Julien; Kao, William; Emery, Evelyne; Berro, David Hassanein; Castera, Laurent; Goardon, Nicolas; Lacroix, Joëlle; Lange, Marie; Capel, Aurélie; Leconte, Alexandra; Andre, Benoit; Léger, Angélique; Lelaidier, Anaïs; Clarisse, Bénédicte; Stefan, Dinu.
Afiliação
  • Lesueur P; Radiation Oncology Department, Centre François Baclesse, 3 avenue du Général Harris, F-14076, Caen, France. Paul.lesueur89@gmail.com.
  • Lequesne J; Normandy university, University of Caen Basse Normandie, 14000, Caen, France. Paul.lesueur89@gmail.com.
  • Grellard JM; Clinical Research Department Centre François Baclesse, Caen, France.
  • Dugué A; Clinical Research Department Centre François Baclesse, Caen, France.
  • Coquan E; Clinical Research Department Centre François Baclesse, Caen, France.
  • Brachet PE; Clinical Research Department Centre François Baclesse, Caen, France.
  • Geffrelot J; Medical Oncology Department, Centre François Baclesse, 14076, Caen, France.
  • Kao W; Clinical Research Department Centre François Baclesse, Caen, France.
  • Emery E; Medical Oncology Department, Centre François Baclesse, 14076, Caen, France.
  • Berro DH; Radiation Oncology Department, Centre François Baclesse, 3 avenue du Général Harris, F-14076, Caen, France.
  • Castera L; Radiation Oncology Department, Centre François Baclesse, 3 avenue du Général Harris, F-14076, Caen, France.
  • Goardon N; Normandy university, University of Caen Basse Normandie, 14000, Caen, France.
  • Lacroix J; Neurosurgery Department, CHU de Caen, Caen, France.
  • Lange M; Normandy university, University of Caen Basse Normandie, 14000, Caen, France.
  • Capel A; Neurosurgery Department, CHU de Caen, Caen, France.
  • Leconte A; Genetic and oncology biology Department, Centre François Baclesse, Caen, France.
  • Andre B; Genetic and oncology biology Department, Centre François Baclesse, Caen, France.
  • Léger A; Radiology Department, Centre François Baclesse, Caen, France.
  • Lelaidier A; Clinical Research Department Centre François Baclesse, Caen, France.
  • Clarisse B; UNICAEN, INSERM, U1086 Anticipe, Normandie University, 14076, Caen, France.
  • Stefan D; Clinical Research Department Centre François Baclesse, Caen, France.
BMC Cancer ; 19(1): 198, 2019 Mar 04.
Article em En | MEDLINE | ID: mdl-30832617
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article